Table 5.
Distribution of histologic subtypes among patients undergoing fertility-sparing surgery in FIGO stage I ovarian cancer
| Study | Serous | Mucinous | Endometrioid | Clear cell | Other/not specified | Total cases |
|---|---|---|---|---|---|---|
| Chen et al. (2020) | 35 | 28 | 11 | 8 | 0 | 82 |
| Birge et al. (2022) | 4 | 11 | 1 | 0 | 18 | 34 |
| Agulto-Mercadal et al. (2020) | 0 | 0 | 0 | 0 | 18 | 18 |
| Lin et al. (2022) | 35 | 28 | 11 | 8 | 0 | 82 |
| Ko et al. (2023) | 1 | 15 | 7 | 10 | 0 | 33 |
| Park et al. (2016) | 3 | 7 | 5 | 3 | 0 | 18 |
| Watanabe et al. (2020) | 5 | 16 | 5 | 3 | 0 | 29 |
| Johansen et al. (2020) | 3 | 18 | 10 | 3 | 2 | 36 |
| Ghalleb et al. (2019) | 3 | 0 | 0 | 0 | 5 | 8 |
| Abdelsalam et al. (2022) | 15 | 7 | 3 | 0 | 0 | 25 |
| Swift et al. (2022) | 0 | 0 | 11 | 0 | 0 | 11 |
| Jiang et al. (2017) | 9 | 52 | 27 | 20 | 0 | 108 |
| Gouy et al. (2017) | 0 | 6 | 0 | 0 | 0 | 6 |
| Letourneau et al. (2015) | 0 | 0 | 0 | 0 | 0 | 0 |
| Johansen et al. (2019) | 0 | 0 | 0 | 0 | 57 | 57 |
| Khatun et al. (2020) | 0 | 1 | 0 | 0 | 0 | 1 |
| Nitecki et al. (2021) | 9 | 52 | 27 | 20 | 45 | 153 |